Skip to main content

Global Genetic Testing Market Report 2022-2027 - Growing Demand for Direct-To-Consumer (DTC) Genetic Testing - ResearchAndMarkets.com

The "Global Genetic Testing Market (2022-2027) by Type, Technology, Applications, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Genetic Testing Market is estimated to be USD 10.43 Bn in 2022 and is projected to reach USD 19.96 Bn by 2027, growing at a CAGR of 13.86%.

Market dynamics are forces that impact the prices and behaviors of the Global Genetic Testing Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service.

Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score.

The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Genetic Testing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The report analyses the Global Genetic Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Some of the companies covered in this report are

  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Centogene
  • Color Genomics
  • Coopersurgical
  • Eurofins Scientific
  • F Hoffmann La Roche
  • Fulgent Genetics
  • Health Network Laboratories
  • Invitae
  • Laboratory of America Holdings
  • Macrogen
  • Myriad Genetics
  • OPKO Health
  • PerkinElmer
  • PreventionGenetics
  • Progenity
  • QIAGEN
  • Quest Diagnostics
  • Sanofi
  • Strand Life Sciences
  • Thermo Fisher Scientific

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

4.1 Drivers

4.1.1 Growing Application of Genetic Testing in Oncology and Genetic Diseases

4.1.2 Growing Adoption of Precision Medicine Diagnostic Techniques

4.1.3 Rising Implementation of Personalized Medicine Applications to Treat Chronic Disorders

4.1.4 Growing Demand for Direct-To-Consumer Genetic Testing

4.2 Restraints

4.2.1 Lack of Experienced Professionals

4.2.2 Social and Ethical Implications of Genetic Testing

4.3 Opportunities

4.3.1 Stringent Regulatory for Product Approvals

4.3.2 Technological Advances in the Field of Genetic Testing and Panels for ECS

4.4 Challenges

4.4.1 High Cost of Next Generation Sequencing

5 Market Analysis

5.1 Regulatory Scenario

5.2 Porter's Five Forces Analysis

5.3 Impact of COVID-19

5.4 Ansoff Matrix Analysis

6 Global Genetic Testing Market, By Type

6.1 Introduction

6.2 Carrier Testing

6.3 Diagnostic Testing

6.4 New Born Screening

6.5 Pharmacogenomics

6.6 Preimplantation Testing

6.7 Prenatal Testing

6.8 Presymptomatic and Predictive Testing

7 Global Genetic Testing Market, By Technology

7.1 Introduction

7.2 Cytogenetics

7.3 DNA Sequencing

7.4 Gene Expression Profiling

7.5 Microarrays

7.6 PCR

8 Global Genetic Testing Market, By Applications

8.1 Introduction

8.2 Autoimmune Disorders

8.3 Cancer

8.4 Chronic Diseases

8.5 Genetic Disorders

8.6 Neurodegenerative Diseases

9 Americas' Genetic Testing Market

9.1 Introduction

9.2 Argentina

9.3 Brazil

9.4 Canada

9.5 Chile

9.6 Colombia

9.7 Mexico

9.8 Peru

9.9 United States

9.10 Rest of Americas

10 Europe's Genetic Testing Market

11 Middle East and Africa's Genetic Testing Market

12 APAC's Genetic Testing Market

13 Competitive Landscape

13.1 Competitive Quadrant

13.2 Market Share Analysis

13.3 Strategic Initiatives

13.3.1 M&A and Investments

13.3.2 Partnerships and Collaborations

13.3.3 Product Developments and Improvements

14 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/ugri14

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.